Dobutamine stress echocardiography during follow-up surveillance in heart transplant patients: Diagnostic accuracy and predictors of outcomes

Dobutamine stress echocardiography during follow-up surveillance in heart transplant patients: Diagnostic accuracy and predictors of outcomes
复制标题

DOI:
10.1016/j.healun.2014.11.019
复制
发表时间:
2015-05-01
影响因子:
8.9
通讯作者:
Desai, Milind Y.
Desai, Milind Y.
中科院分区:
医学1区
文献类型:
--
作者:
Chirakarnjanakorn, Srisakul;Starling, Randall C.;Desai, Milind Y.

文献摘要

被引文献

相似文献

背景技术背景:心脏移植物血管病变(CAV)是原位心脏移植(OHT)后3年以上移植物衰竭和死亡的主要原因,通常使用多巴酚丁胺负荷超声心动图(DSE)进行评估。我们试图研究:(a)DSE阳性结果的发生率和诊断准确性;以及。(b)方法:我们研究了497例连续的OHT患者(63 +/- 10岁,78%为男性),他们在1998年至2013年期间在我们中心接受了DSE作为常规监测的一部分。对随访期间进行的每次DSE和冠状动脉造影进行了审查。根据国际心肺移植学会2010年的建议,对CAV进行了重新分级。复合事件(死亡,冠状动脉血运重建,心肌梗死和再次移植)recorded.Results:有1,243 DSE研究中进行的中位数为8.7(6.2至11.9)年移植后。只有22项研究(1.8%)为阳性,978项(78.7%)为阴性,243项(19.5%)为非诊断性(次最大心率反应)缺血。在497例患者中,只有20例(4%)至少有一项阳性DSE研究。有310例诊断性DSE在1年内进行了冠状动脉造影。DSE检测CAV的敏感性、特异性、阳性预测值和阴性预测值分别为7%、98%、82%和41%,检测CAV 2级和3级的敏感性、特异性、阳性预测值和阴性预测值分别为28%、98%、71%和89%。DSE期间无死亡。在DSE后5.6 +/- 3.6年,有201例(40%)事件。CAV的程度(而不是DSE为基础的缺血,p = 0.3)独立预测预后(p < 0.001)。结论:在接受DSE监测的OHT患者中,阳性结果的发生率非常低。DSE对早期CAV的检测灵敏度不够。CAV的程度而不是基于DSE的缺血独立预测结果。(C)2015年国际心肺移植学会。All rights reserved.
BACKGROUND: Cardiac allograft vasculopathy (CAV), a major cause of graft failure and mortality at >3 years after orthotopic heart transplantation (OHT), is commonly evaluated using dobutamine stress echocardiography (DSE). We sought to study: (a) the incidence of positive results and diagnostic accuracy of DSE; and.(b) the predictors of adverse outcomes in OHT patients.METHODS: We studied 497 consecutive patients (63 +/- 10 years, 78% men) with OHT who had undergone DSE as part of routine surveillance at our center between 1998 and 2013. Every DSE and coronary angiogram performed during follow-up was reviewed. CAV was regraded according to the 2010 recommendations of the International Society for Heart and Lung Transplantation. Composite events (death, coronary revascularization, myocardial infarction and retransplantation) were recorded.RESULTS: There were 1,243 DSE studies performed during a median of 8.7 (6.2 to 11.9) years after transplantation. Only 22 studies (1.8%) were positive, 978 (78.7%) were negative and 243 (19.5%) were non-diagnostic (sub-maximal heart rate response) for ischemia. Among 497-patients, only 20 (4%) had at least one positive DSE study. There were 310 diagnostic DSEs with coronary angiograms performed within 1 year of one another other. In this subgroup, the sensitivity, specificity, positive predictive value and negative predictive value of DSE were 7%, 98%, 82% and 41%, respectively, to detect any CAV, and 28%, 98%, 71% and 89% to detect CAV Grades 2 or 3, respectively. There were no deaths during DSE. At 5.6 +/- 3.6 years after DSE, there were 201 (40%) events. Degree of CAV (and not DSE-based ischemia, p = 0.3) independently predicted outcomes (p < 0.001).CONCLUSIONS: The incidence of a positive result is very low in OHT patients undergoing surveillance DSE. DSE is insufficiently sensitive for detection of early CAV. Degree of CAV and not DSE-based ischemia independently predicted outcomes. (C) 2015 International Society for Heart and Lung Transplantation. All rights reserved.